Diane M. Simeone
0000-0001-5142-3087
Publication & Citation Trends
Publications
0 total
The PRECEDE consortium: A longitudinal international cohort study of high-risk individuals for the development of pancreatic cancer
Cited by 0
Semantic Scholar
The Pancreatic Cancer Early Detection (PRECEDE) Study is a Global Effort to Drive Early Detection: Baseline Imaging Findings in High-Risk Individuals. OA
Cited by 16
Semantic Scholar
Somatic Mutational Analysis in Endoscopic Ultrasound–Guided Biopsy of Pancreatic Adenocarcinoma: Assessing Yield and Impact
Cited by 1
Semantic Scholar
312 LOW DOSE DOUBLE EPIGENETIC THERAPY IMPROVES IMMUNOTHERAPY RESPONSE AND PROLONGS SURVIVAL IN PANCREATIC CANCER.
Cited by 0
Semantic Scholar
The role of family history in predicting germline pathogenic variant carriers who develop pancreatic cancer: Results of a multicenter collaboration OA
Cited by 2
Semantic Scholar
S129 Pancreatic Findings by Germline Mutation Status and Imaging Modality in Patients Undergoing Screening for Pancreatic Ductal Adenocarcinoma OA
Cited by 0
Semantic Scholar
Research Topics
Pancreatic and Hepatic Oncology Research
(282)
Cancer Genomics and Diagnostics
(132)
Cancer Cells and Metastasis
(103)
Cancer Research and Treatments
(50)
Epigenetics and DNA Methylation
(47)
Affiliations
AstraZeneca (United Kingdom)
Northwestern University
Ontario Institute for Cancer Research
Brigham and Women's Hospital
Dartmouth–Hitchcock Medical Center